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New Haven. Connecticut 
The past several years have witnessed a rapid expansion in 
the development of nuclear magnetic resonance (NMR) for 
both clinical research and diagnosis. We can anticipate for 
reasons described later in this article, that this effort will 
have a significant impact on the clinical and investigational 
assessment of cardiovascular disease. This surge of interest 
involves two major and distinct areas of NMR development: 
NMR spectroscopy and NMR imaging. NMR imaging (also 
called magnetic resonance imaging or MRI) has stirred con-
siderable excitement with the expectation that this meth-
od may complement or in some cases supplant other cur-
rently used methods of cardiovascular anatomic imaging 
such as echocardiography, radionuclide techniques, digital 
subtraction angiography or computed tomographic scan-
ning. Ultimately, factors of spatial resolution, cost, time 
required per patient study, instrument availability and port-
ability as well as the advantage afforded by employing non-
ionizing radiation will determine the role of NMR imaging 
within the diagnostic and investigational armamentarium 
(1,2). Perhaps of greater significance to the long-term role 
of NMR in the study of heart disease are recent and con-
tinuing developments in the field of NMR spectroscopy. 
NMR Spectroscopy: Physical Principles 
NMR spectroscopy is to be distinguished from NMR 
imaging and other conventional imaging techniques in that 
a structural image of an organ or tissue is not obtained. 
Rather, NMR spectroscopy provides a limited, nondestruc-
tive biochemical analysis in the form of a spectrum (Fig. 
I). A fuller grasp of the importance of some of the newer 
developments in NMR spectroscopy and how they are likely 
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to affect its use as an investigational method for human 
biology requires some familiarity with the basic NMR method. 
Both NMR imaging and NMR spectroscopy are based on 
the observation that certain nuclei act as if they are spinning 
about an axis. When placed in a magnetic field, the nuclear 
spin axis will orient in a parallel or anti parallel direction 
relative to this applied field with slightly more nuclei aligned 
in the more favorable parallel orientation. Only nuclei that 
possess "spin" experience this reorientation and only these 
nuclei are "visible" in an NMR spectrum. The nuclei in 
the preferred parallel orientation relative to the applied field 
can be stimulated and thrown into the less energetically 
favorable anti parallel orientation by a "pulse" of radio-
frequency power. After such a pulse the nuclei tend to relax 
back to their initial preferred parallel alignment and in doing 
so emit a radiofrequency signal. The frequency of this emit-
ted signal is determined by the nucleus from which it orig-
inated and the magnetic field experienced by that nucleus. 
This emitted signal is captured by a receiver and, depending 
on the particular experimental setting, the information en-
coded in this signal is processed through a computer and 
used to construct either an image or a spectrum of the sample 
or subject analyzed. A complete and very readable discus-
sion of the physical basis of NMR spectroscopy can be found 
in the monograph by Gadian (3). 
Study of Changes in Cardiac Metabolism 
It is particularly fortunate that development of NMR 
spectroscopy, as a method of nondestructive in vivo bio-
chemical analysis, is reaching a stage of application at a 
time when myocardial salvage after ischemic injury is under 
intense investigation. Defining the sequence of changes in 
myocardial high energy phosphate content and tissue pH 
during periods of ischemia and reperfusion is one area that 
will receive experimental attention using this technique. 
When combined with measurements of regional and global 
left ventricular function, NMR spectroscopy will provide a 
unique opportunity to study changes in cardiac metabolism 
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Figure 1. Phosphorus NMR spectrum of the heart obtained in 
vivo in an anesthetized guinea pig whose heart was surgically 
exposed and positioned close tei a solenoidal receiver coil. The x 
axis is partitioned in units that correspond to the frequency of the 
emitted radio pulse from the phosphorus nuclei. The y axis pro-
vides a measure of the strength of a signal such that under appro-
priate conditions the area under the individual peaks corresponds 
to the number of phosphorus-3l nuclei in each chemical species. 
The y axis is divided into units of parts per million (PPM) of the 
field strength. Distinct peaks arise from each of the three phos-
phorus-3l atoms of adenosine triphosphate (ATP) and from the 
single phosphorus-3l atoms of inorganic phosphorus (Pi) and phos-
phocreatine (Per). They are seen as separate peaks because the 
local magnetic field experienced by each of these atoms is slightly 
different and hence the resonance frequency differs. The small 
peak to the left of Pi probably arises froin the phosphorus of sugar 
phosphates and from the 3-phosphate of 2,3-DPG within eryth-
rocytes in the ventricular chamber. 
that accompany cardiac muscle dysfunction in acute and 
chronic ischemic heart disease as well as in diffuse processes 
such as cardiomyopathy and ventricular hypertrophy. 
In the past several years, the capability of NMR spec-
troscopy to perform repetitive, nondestructive, quantitative 
measurements of the myocardial content of high energy 
phosphates (4,5), lactate (6), glycogen (6), Krebs cycle 
intermediates (6,7) and tissue pH (8) has been convincingly 
demonstrated in vitro and in vivo in experimental anilnals. 
Recognition of this biochemical analytic capability, coupled 
with a successiort of recent technical advances, has led to 
the expansion of the scope of NMR spectroscopy from a 
laboratory tool of the chemist to a method readily applicable 
to the biochemical study of a wide range of physiologic and 
pathophysiologic phenomena. 
For NMR spectoscopy the biochemical analysis is limited 
to sensitive nuclei that possess the property of nuclear spin. 
Among these nuclei the proton, phosphorus-31e1p), car-
bon-13(l3C), fluorine-19(l9p) and sodium-23CZ3NA) are of 
greatest interest for in vivo spectroscopy. However, even 
these nuclei provide a useful signal only when they are 
present in sufficient concentrations (around 1 mM or greater 
for 31p and l3C, 10- to 20-fold lower for protium eH] and 
19F) and only when they are relatively mobile. This latter 
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limitation is illustrated by the fact that phospholipids and 
the nucleic acids, DNA and RNA, which are the most abun-
dant 3lP-containing compounds in most nucleated cells, do 
not give rise to distinct peaks in a typical phosphorus NMR 
spectrum (Fig. 1). 
Furthermore, the ability to observe and quantitate signals 
from any given nucleus will depend on several factors in-
cluding I) the strength of the applied magnetic field, 2) the 
radiofrequency pulse sequence used to excite the nuclei, 3) 
the design characteristics of the receiver system, and 4) the 
computer-processing capability of the spectrometer. De-
velopment in each of these four areas underlies current ef-
forts to use NMR spectroscopy for in vivo studies of myo-
cardial biochemistry. 
Advances in Technology 
In vivo NMR spectroscopy, unlike NMR imaging, re-
quires a very high magnetic field to provide useful spectral 
sensitivity and resolution. As a result, a limiting factor in 
development of NMR spectroscopy for application to in vivo 
biologic studies has been the availability of superconducting 
magnets with a field strength of 1.5 tesla (15,000 gauss) or 
greater and a sufficiently large bore to accommodate ex-
perimental animals and ultimately humans. Recently, su-
perconducting magnets with fields of up to 2 tesla and a 
bore of up to I m have become available. This will permit 
detailed spectroscopic study of regional and global myo-
cardial metabolism in actual disease states as well as in 
complex instrumented experimental animal models. 
The expansion in magnet technology has occurred in 
parallel with the development and application of complex 
pulse sequences selected either to achieve optimal signal to 
noise ratio for the metabolite or metabolites being studied 
or, when possible, to localize the detected signals to a spe-
cific anatomic volume. The use of selective pulse sequences 
to optimize signal to noise ratio is illustrated by the recent 
development of pre saturation (9) and 'H-homonuclear dou-
ble resonance difference (10) methods for in vivo proton 
spectroscopic studies of the brain. These methods are de-
signed to discriminate signals from protons of tissue me-
tabolites from abundant water and fat proton signals. 
Use of radiofrequency pulses selected for their ability to 
localize the origin of spectral data to a specific volume has 
recently been studied in conjunction with the use of specially 
designed surface coils (11,12). The problems encountered 
in localizing the origin of the NMR signal when dealing 
with ail intact animal are not trivial. In an effort to limit the 
source of the NMR signal, virtually all in vivo myocardial 
studies using NMR have involved some surgical manipu-
lations to allow at least close apposition of the heart in the 
receiver coil. Extension of NMR spectroscopic methods to 
humans will likely require refinement of noninvasive meth-
ods in which the transmitting (and receiving) radiofrequency 
coil remains in the skin surface. A surface coil technique 
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has been used successfully to measure high energy phos-
phorus metabolism and pH in forearm skeletal muscle in 
humans (13). With this technique. a simple loop of copper 
wire placed on the skin surface is used as the receiver coil. 
and signals arising from a variety of sites within skin and 
subcutaneous tissues adjacent to the coil where there is a 
strong homogenous magnetic field are picked up by the 
surface coil. While well suited for study of forearm or leg 
muscle. the present rudimentary methods will need modi-
fication to be applicable to the deeper (and moving) myo-
cardial tissue. A long range goal. which admittedly is not 
close to our current grasp, would be to obtain "chemical 
shift" images of tissues, that is. pictures of the distribution 
of metabolites such as adenosine triphosphate (ATP), phos-
phocreatine or lactate within a tissue. 
It has been recently appreciated (11.12) that modification 
of the radiofrequency pulse sequence can provide a method 
to selectively sample from only some portion of the sensitive 
volume normally subtended by the surface coil. Adaptation 
of such volume-selective pulse sequences to studies in vivo 
is at an early stage of development and goes hand in hand 
with experimentation with different configurations of sur-
face coils. Together they will be a very important area of 
NMR development over the next few years. Alternative 
approaches to signal localization are being explored as evi-
denced by recent reports describing receiver coils that can 
be either chronically implanted (14) or introduced trans-
venously as a "catheter-coil" (15). 
The final area of technical advance extending over a 10 
to 15 year period has involved the improved computer meth-
ods available for analysis of the emitted signal. This has 
been most clearly illustrated by the routine application of 
Fourier transform analysis of the radiofrequency signal spec-
trum but has been similarly important in other aspects of 
spectral processing and quantitation. 
Experimental Applications 
As NMR spectroscopy is applied increasingly to studies 
of cardiac pathophysiology in intact animals and humans, 
almost certainly phosphorus will be the first nucleus studied 
extensively. This is a natural consequence of the unique 
capability of 3IP-NMR to measure myocardial content of 
A TP, phosphocreatine and inorganic phosphorus and pH. 
The biologic importance of these measurements with respect 
to myocardial viability is obvious. Measurement of these 
phosphate compounds is possible because the naturally 
abundant isotope of phosphorus e1p) is NMR-"visible," 
and because these compounds are present in relatively high 
concentrations (1 mM for inorganic phosphorus, up to 8.0 
mM for phosphocreatine) in myocardial cytosol. In studies 
of the isolated perfused heart 3Ip_NMR has already been 
used to measure the time course of decline of high energy 
phosphates and pH in the globally ischemic heart (5) and 
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the influence of altered perfusate composition on the respose 
to ischemia (16). It also has been possible to measure changes 
in the cellular A TP level that occur within the cardiac cycle 
in the perfused heart (17). Studies (18,19) on small animals 
have demonstrated the applicability of 3IP_NMR to exam-
ining the high energy phosphorus pool in vivo. In the live 
guinea pig significant changes in cellular creatine phosphate 
and inorganic phosphorus signals can be observed within 
20 seconds of anoxia. In serial spectra obtained in this 
experimental model the halftime of decline of phospho-
creatine in response to anoxia was found to be 54 seconds. 
Restoration of oxygen led to an equally rapid restitution of 
phosphocreatine to control concentrations (18). In similar 
experiments, myocardial ATP content did not change sig-
nificantly during periods of anoxia extending to 4 to 5 min-
utes despite the near complete utilization of phosphocreatine 
stores. Such observations suggest that in vivo changes in 
the phosphocreatine signal may provide a more sensitive 
indicator of tissue oxygen lack than the content of A TP as 
such. An increase in the inorganic phosphate signal pro-
portional to the decline in phosphocreatine might be ex-
pected, but this phosphate can be lost from the myocyte and 
carried away in the circulation. In studies of guinea pig 
heart, the inorganic phosphate signal did increase but not 
in strict proportion to the phosphocreatine decline (18). 
While the majority of 3IP-NMR studies using isolated 
heart preparations have examined global myocardial phos-
phorus metabolism, regional changes in phosphocreatine, 
A TP and pH also have been monitored in the isolated dog 
heart (20) and more recently in intact animals (21). With 
the availability of larger magnets we can anticipate that high 
energy phosphorus metabolism and myocardial pH will be 
studied extensively during regional ischemia and reperfusion 
after ischemia. Using such a method the effect of intracel-
lular pH and of cellular A TP and phosphocreatine on con-
tractile function and electrical irritability during ischemia 
can be examined in vivo. In addition, tissue viability during 
myocardial reperfusion can be assessed in a continuous "on 
line" fashion and the effect of therapeutic strategies directed 
at myocardial preservation evaluated. Other than spectrom-
eter availability, no significant technologic obstacles pre-
clude such studies in large animals. 
Recent work has indicated that 13C (22) and the IH-proton 
nucleus can also be studied in vivo using surface coils (9,10). 
13C spectroscopy already has been used in studies of myo-
cardial metabolism in vivo (6) and in vitro (7). It appears 
particularly well suited to investigation of fuel metabolism 
(glycogen synthesis and mobilization) and of Krebs cycle 
activity. The low natural abundance (~1.1 %) of the I3C_ 
nucleus in nature necessitates that, for many applications, 
I3C-labeled compounds be infused before spectroscopic 
analysis to enrich the endogenous pools. These compounds 
are stable (nonradioactive) isotopes and can be used safely 
in humans. However, the cost of isotopes may limit use of 
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this technique to studies in smaller laboratory animals. 
Nevertheless, the high cost of such isotope experiments is 
partially offset by being able to measure serially and si-
multaneously the resonance signals arising from multiple 
(perhaps 15 to 20) compounds and therefore to "trace" 
multiple metabolic pathways in a single experiment. Details 
of the use of 13C-NMR in biologic studies have been recently 
reviewed (23). 
Proton Spectroscopy 
Results of work in proton spectroscopy in the intact an-
imal is one of the most exciting recent developments in 
biologic NMR spectroscopy. Proton spectroscopy should be 
distinguished from conventional proton NMR imaging. In 
the former, spectra are obtained from multiple compounds 
(for example, water, side chains of fatty acids, lactate), 
each at a resonance frequency characteristic of the com-
pound of origin and each producing a signal at a known 
position in the spectrum. In contrast, construction of typical 
proton images depends on the density relaxation properties 
of the water protons alone. Indeed, a major difficulty with 
in vivo proton spectroscopy involves discerning signals aris-
ing from biochemical compounds of interest from the large 
background water signal. The magnitude of this problem is 
readily appreciated by considering that water in biologic 
tissues is present at a concentration of 35 to 40 M (or 70 
to 80 M water protons) while compounds of interest such 
as glucose, lactate and various amino acids are present in 
heart tissue in millimolar concentrations or less. The am-
plitude of the water proton signal then could be approxi-
mately 105 times greater than that from the protons of me-
tabolites. The problem is further confounded by the rather 
narrow proton spectral width with overlap of some proton 
resonances from metabolites (for example, glucose) with 
the water proton resonances. 
Newer techniques using selective pulse sequences and 
spectral editing have produced major advances in devel-
opment of in vivo proton spectroscopy. Lactate, alanine, 
glutamate, creatine and other metabolites have been iden-
tified in vivo in proton spectra from rat brain, and reversible 
changes in rat brain lactate content during episodes of hy-
poxemia have been demonstrated (9). In vivo proton spec-
troscopy offers the possibility to enhance substantially the 
ultimate sensitivity of in vivo NMR spectroscopy. For car-
bon or phosphorus nuclei, NMR sensitivity is limited to 
detecting compounds present in concentrations of approx-
imately I millimolar or greater. The proton has a 15- to 40-
fold greater intrinsic sensitivity. Theoretically, proton spec-
toscopy would allow quantitation of compounds present in 
the 100 p.,M range, which includes many cellular metabolites 
of interest (for example, glycolytic intermediates, intracel-
lular amino acids and some Krebs cycle intermediates). In 
the particular case of myocardial ischemia, tissue lactate 
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concentration is known to increase from I to between 10 
and 30 mM (30 to 90 mM lactate methyl protons). This 
large change in substrate concentration, coupled with the 
greater sensitivity of the proton signals, would support the 
expectation that spectroscopic measurement of lactate con-
tent could provide a very sensitive marker of tissue ischemia. 
Future Applications 
Clearly these next several years will be exciting times 
for the application of current NMR spectroscopic methods 
to the study of myocardial high energy phosphate and fuel 
metabolism. In addition to studies of regional heart function 
and metabolism during ischemia and reperfusion, we can 
expect that experimental animal models of heart failure, 
drug-induced cardiotoxicity and ventricular hypertrophy will 
be examined extensively. Currently, newer work in the area 
of in vivo proton spectroscopy provides particular enthu-
siasm for development of noninvasive cardiac spectroscopy 
in humans. 
For the present, practical difficulties with localization of 
the signal source, limitations on sensitivity imposed by the 
intrinsic lack of sensitivity of the phosphorus and carbon 
nuclei and the significant cost of the magnet and spectrom-
eter are likely to limit application of NMR spectrometry to 
cardiac research in a few large centers. However, if NMR 
spectroscopy proves a safe, sensitive, noninvasive method 
of monitoring regional myocardial metabolism, then its fu-
ture will be assured as a new diagnostic and investigational 
technique providing heretofore unavailable information and 
insight. 
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